Parana Copper Corporation (CSE:COPR) (OTC:PNNRF) (Frankfurt:O3X4) (the “Company”) announces Biominerales Pharma Corp. (“BMP”) as the latest client of the merchant bank, Redfund Capital Corp.

BMP and its wholly owned Colombian subsidiary Biominerales Pharma S.A.S. (“BMP Colombia” ) was established in 2014 by a group of Canadian and Colombian entrepreneurs and is the only biodiesel refinery in Colombia which uses cooking and vegetable oils and has the capacity to produce biodiesel meeting ISCC international standard. The established team took the initiative in 2015 when medicinal cannabis was decriminalized in Columbia and saw an opportunity to diversify while leveraging on their existing operations, which resulted in the creation of Biominerales Pharma. In 2017, BMP was granted global extraction and exportation licenses for medicinal cannabis oil. The BMP team is located in offices in Bogota, and currently partners with 180 experienced cultivators, chemical engineers, agronomists and top local and international doctors. Their cannabis cultivation is underway and their first crop will be harvested in late August 2018. BMP will have access to high CBD and high THC content products. Once certification is obtained from the Instituto Colombiano Agropecuario, BMP Colombia will be one of the first of a small number of companies to be authorized to legally market medical cannabis in Colombia.


Since medicinal cannabis was legalized it has allowed Colombia to become a global player and fostered an exciting environment and momentum for the country to become a participant in the international cannabis market with its excellent year-round growing conditions and long history of a strong agriculture industry. The Canadian public markets have embraced Colombia as one of the few South American countries with completed legislation and cannabis licenses granted. Nonetheless; not all cannabis licenses granted are the same and some are limited to exportation only in South America or only for research and development. It is those companies who can extract, produce and export globally who will help Colombia take a key role in the medicinal cannabis industry.

“As we expand our clientele, our goal is to work with companies who have revenue and have shown they are leaders in the cannabis industry. BMP’s cannabis licenses, ability to export globally, near term revenues on their cultivation, make them an immediate leader in Colombia. There has been much hearsay on companies in the country that we are pleased to be partnering with a successful entity with an already established footprint,” stated Meris Kott, CEO.

As previously released, Parana Copper Corp. has been informed that following the CSE’s review of the Company’s application in respect to its previously announced name change to Redfund Capital Corp. in conjunction with a change of business, the CSE has approved the Company’s proposed change of business. A date for the resumption of trading will be determined upon confirmation of the completion of a private placement, as well as completion of the usual application documentation and fees pursuant to CSE policies.

For additional information:

Email to info@paranacoppercorp.com  or  info@redfundcapitalcorp.com

Phone: 604-484-8989

Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein

Source: ca.finance.yahoo.com

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less